Search results for: Innovation Policy Prize
Filter search results
Biotechnology and the Economics of Discovery in the Pharmaceutical Industry
1 October 1998
This paper examines the economic aspects of the forces driving the emergence of biotechnology firms, and the implications of this for the organisation of research and development (R&D) and industrial…
Disease Management, the NHS and the Pharmaceutical Industry
1 March 1999
Share this: Download publication Anne R. Mason Michael F. Drummond Adrian Towse Disease management is a term with multiple and ambiguous meanings. For some, it is purely a form of…
Pharmaceuticals Among the Sunrise Industries
1 February 1984
The performance of the United Kingdom economy has been the subject of much critical comment in recent years. Of course, economic achievement can be viewed from many different perspectives, giving…
Pharmaceuticals in Developing Countries 1981-82
1 July 1984
Two years ago, the Office of Health Economics published a research paper describing some of the activities of eighteen European pharmaceutical companies in the Developing Countries in ·1979-80 (Worlock 1982)….
Pharmaceuticals in seven nations
1 May 1985
Great Britain at the suggestion of and in close collaboration with Medizinisch Pharmazeutische Studiengesellschaft (MPS) in the Federal Republic of Germany, OHE is funded entirely by the Association of the…
Biosimilar Competition: Lessons from Europe and Prospects for the US
1 October 2014
Based on an OHE lunchtime seminar by Professor Henry Grabowski, this seminar briefing explores the lessons learned from Europe’s experience with biosimilars, and provides an analysis of how the US…
Assessing the Use of Multi-indication Medicines: A Review of Current Data Capabilities in the UK
1 March 2015
…Northern Ireland. The report highlights upcoming initiatives that may alter this landscape, describes three promising local programmes that demonstrate opportunities for expanding capabilities, and makes a series of policy recommendations….
International Comparison of Medicines Usage: Quantitative Analysis from a Swedish Perspective
1 May 2015
The OHE undertook an analysis of the uptake of medicines in 13 high income countries. The UK perspective on this was published in November 2014 by the ABPI. OHE has…
Incorporating Life-cycle Price Modelling into Pharmaceutical Cost-effectiveness Evaluations
1 August 2015
Why might the launch price of a new drug be a poor indicator of future expenditure for a drug? Which are the factors that determine the future prices and market…